Clinical Trials: Groundbreaking Research Under Way at LI Hospitals
Newsday highlights clinical trial research at several Long Island medical institutions and included commentary from Scott A. Rodeo, MD, sports medicine surgeon and Vice Chair of Orthopaedic Research and Co-director of the Orthopaedic Soft Tissue Research Program at HSS.
Dr. Rodeo said, “Hospital for Special Surgery, which recently expanded HSS Long Island in Uniondale, conducts clinical trials to evaluate new treatments and better understand musculoskeletal disorders. These are conditions that affect the muscles, bones and joints. Our patients often participate in a clinical trial to help generate knowledge that will improve their own treatment or will one day benefit people with the same condition. As a foremost center for orthopedic surgery, we conduct research on new technologies and techniques such as robotic-assisted, less invasive spine surgery and joint replacement; the use of a biologic treatment during rotator cuff surgery to enhance healing, and a new technique for ACL repair, to name a few. Basic science research in the laboratory at HSS lays the groundwork for many of our clinical trials, and we have a robust infrastructure in place. This synergy between basic science researchers and those conducting clinical trials is one of our greatest strengths. In the area of rheumatology, HSS physicians and investigators are involved in vital research to find new and better treatment approaches to improve quality of life for people with rheumatoid arthritis, lupus, scleroderma and other autoimmune diseases. HSS is leading the way in clinical trials focusing on pain management after orthopedic surgery. Researchers have published a number of studies on ‘multimodal analgesia,’ which targets multiple pain pathways to reduce the amount of opioid medication needed after surgery. Patient registries are a critical part of our research at HSS. These extensive databases enable us to track patients and evaluate outcomes over the long term. More than 70 registries follow well over 100,000 HSS patients. Along with clinical trials, this gold mine of patient data will enable us to improve patient care.”
The full article appeared in a special print edition of Newsday TopDoctors on Long Island on July 19, 2022.